DK2394638T3 - Nye farmaceutiske sammensætninger - Google Patents
Nye farmaceutiske sammensætningerInfo
- Publication number
- DK2394638T3 DK2394638T3 DK11169599.5T DK11169599T DK2394638T3 DK 2394638 T3 DK2394638 T3 DK 2394638T3 DK 11169599 T DK11169599 T DK 11169599T DK 2394638 T3 DK2394638 T3 DK 2394638T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical compositions
- new pharmaceutical
- new
- compositions
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2010/04754A TR201004754A1 (tr) | 2010-06-11 | 2010-06-11 | Yeni Farmasötik Kombinasyonlar |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2394638T3 true DK2394638T3 (da) | 2013-07-15 |
Family
ID=43303905
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK11169599.5T DK2394638T3 (da) | 2010-06-11 | 2011-06-10 | Nye farmaceutiske sammensætninger |
Country Status (7)
Country | Link |
---|---|
US (1) | US20110305757A1 (de) |
EP (2) | EP2586424B1 (de) |
DK (1) | DK2394638T3 (de) |
ES (2) | ES2424469T3 (de) |
PL (2) | PL2394638T3 (de) |
PT (1) | PT2394638E (de) |
TR (1) | TR201004754A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR201007508A1 (tr) * | 2010-09-14 | 2012-04-24 | Sanovel İlaç San. Ve Ti̇c. A.Ş. | Oral yolla dağılan bileşimler |
KR101414873B1 (ko) * | 2012-06-28 | 2014-07-03 | 보령제약 주식회사 | 피마살탄 및 히드로클로로티아지드가 함유된 약제학적 조성물 |
WO2014102628A1 (en) * | 2012-12-31 | 2014-07-03 | Ranbaxy Laboratories Limited | Stable pharmaceutical composition comprising azilsartan medoxomil |
EP3492466B1 (de) * | 2016-07-29 | 2022-06-01 | Wuhan LL Science And Technology Development Co., Ltd. | Orale feste zubereitung und verwendung davon |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2125251C (en) * | 1993-06-07 | 2005-04-26 | Yoshiyuki Inada | A pharmaceutical composition for angiotensin ii-mediated diseases |
WO1997002032A1 (en) * | 1995-06-30 | 1997-01-23 | Merck & Co., Inc. | Method of treating renal disease using an ace inhibitor and an aii antagonist |
CA2720108C (en) * | 2008-03-11 | 2016-06-07 | Depomed, Inc. | Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
CA2715350C (en) * | 2008-03-19 | 2017-02-14 | Ratiopharm Gmbh | Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic |
AR073380A1 (es) * | 2008-09-25 | 2010-11-03 | Takeda Pharmaceutical | Composicion farmaceutica solida. comprimido multicapa |
-
2010
- 2010-06-11 TR TR2010/04754A patent/TR201004754A1/xx unknown
-
2011
- 2011-06-10 EP EP13150074.6A patent/EP2586424B1/de not_active Not-in-force
- 2011-06-10 DK DK11169599.5T patent/DK2394638T3/da active
- 2011-06-10 PT PT111695995T patent/PT2394638E/pt unknown
- 2011-06-10 PL PL11169599T patent/PL2394638T3/pl unknown
- 2011-06-10 ES ES11169599T patent/ES2424469T3/es active Active
- 2011-06-10 PL PL13150074T patent/PL2586424T3/pl unknown
- 2011-06-10 ES ES13150074.6T patent/ES2522873T3/es active Active
- 2011-06-10 EP EP11169599.5A patent/EP2394638B1/de not_active Not-in-force
- 2011-06-13 US US13/159,049 patent/US20110305757A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20110305757A1 (en) | 2011-12-15 |
TR201004754A1 (tr) | 2012-01-23 |
EP2586424A1 (de) | 2013-05-01 |
PL2394638T3 (pl) | 2014-02-28 |
EP2394638B1 (de) | 2013-05-08 |
EP2586424B1 (de) | 2014-08-13 |
ES2424469T3 (es) | 2013-10-02 |
EP2394638A1 (de) | 2011-12-14 |
PL2586424T3 (pl) | 2015-03-31 |
PT2394638E (pt) | 2013-08-22 |
ES2522873T3 (es) | 2014-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SMT201600350B (it) | Composizioni farmaceutiche | |
SMT201700008B (it) | Composizione farmaceutica | |
BR112014003052A2 (pt) | composições farmacêuticas | |
DK3246018T3 (da) | Farmaceutisk sammensætning | |
DK2694038T3 (da) | Farmaceutisk sammensætning | |
SMT201700050B (it) | Composizioni anestetiche termogelificanti | |
CO6852076A2 (es) | Composiciones farmacéuticas inhalables | |
DK2640893T4 (da) | Sammensætninger | |
DK3284467T3 (da) | Nikotinholdige farmaceutiske sammensætninger | |
CO6930367A2 (es) | Composiciones farmaceúticas | |
DK2632493T3 (da) | Lægemiddelindgivelsessammensætninger | |
BR112012031667A2 (pt) | composição | |
EE201300005A (et) | Ravimkoostis | |
DK2654736T3 (da) | Hidtil ukendt farmaceutisk sammensætning | |
BRPI1012539A2 (pt) | composições farmacêuticas | |
BR112012032683A2 (pt) | composição | |
GT201200303A (es) | Formulaciones farmacéuticas | |
IT1394400B1 (it) | Composizioni farmaceutiche | |
CO6940426A2 (es) | Formulaciones farmacéuticas | |
DK2897594T3 (da) | Farmaceutisk sammensætning | |
BR112012032980A2 (pt) | composição | |
CO6801722A2 (es) | Composiciones farmacéuticas | |
DK2815752T3 (da) | Oral farmaceutisk sammensætning | |
BR112013008074A2 (pt) | combinações farmacêuticas | |
SMT201500005B (it) | Composizione framaceutica inalabile |